Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.

Kayleen A BaileyNeeta Pandit-TaskarJohn L HummPat ZanzonicoStephen GilheeneyNai-Kong V CheungKim Kramer

Published in: Journal of neuro-oncology (2019)

131I-Omburtamab appears safe with favorable dosimetry therapeutic index. When used as consolidation following surgery and chemoradiation therapy, 131I-Omburtamab may have therapeutic benefit for patients with ETMR.

Keyphrases

minimally invasive
coronary artery bypass
cancer therapy
squamous cell carcinoma
stem cells
locally advanced
drug delivery
radiation therapy
coronary artery disease
surgical site infection
cell therapy
replacement therapy
smoking cessation